Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump admini… [+2492 chars]Read More
Novo Nordisk cuts directtoconsumer prices for Wegovy Ozempic to 349 a month CNBC
